Mometasone furoate/formoterol (MF/F) combination [clinicaltrials_resource:3074b394036a36b060025efdb9946f06]
intervention [clinicaltrials_vocabulary:intervention]
Mometasone furoate/formoterol (MF/F) combination [clinicaltrials_resource:3074b394036a36b060025efdb9946f06]
Bio2RDF identifier
3074b394036a36b060025efdb9946f06
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3074b394036a36b060025efdb9946f06
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
MF/F 200/10 mcg via a metered dose inhaler (MDI) twice daily for 52 weeks
intervention name [clinicaltrials_vocabulary:intervention-name]
Mometasone furoate/formoterol (MF/F) combination
other name [clinicaltrials_vocabulary:other-name]
SCH 418131
identifier
clinicaltrials_resource:3074b394036a36b060025efdb9946f06
title
Mometasone furoate/formoterol (MF/F) combination
@en
type
label
Mometasone furoate/formoterol ...... 4b394036a36b060025efdb9946f06]
@en